Insiders · Profile

Mancini Marianna

Chief Operating Officer at Viking Therapeutics. Filing since 28 Mar 2023. CIK 0001838112

Company

Date

Role

Action

Shares

Amount

Of holding

VKTX Viking Therapeutics, Inc.

29 Jul 2026

Chief Operating Officer

Sold at will

18,217

$609.64K

4.1%

VKTX Viking Therapeutics, Inc.

5 Jan 2026

Chief Operating Officer

Sold at will

57,661

$1.90M

12.4%

VKTX Viking Therapeutics, Inc.

28 Oct 2025

Chief Operating Officer

Sold at will

6,185

$216.49K

1.6%

VKTX Viking Therapeutics, Inc.

3 Jul 2025

Chief Operating Officer

Sold at will

4,266

$118.47K

1.1%

VKTX Viking Therapeutics, Inc.

6 Jan 2025

Chief Operating Officer

Sold at will

54,215

$2.32M

12.7%

VKTX Viking Therapeutics, Inc.

30 Jul 2024

Chief Operating Officer

Sold at will

18,026

$1.03M

4.7%

VKTX Viking Therapeutics, Inc.

1 May 2024

Chief Operating Officer

Sold on a plan

281,425

$22.14M

44.7%

VKTX Viking Therapeutics, Inc.

17 Apr 2023

Chief Operating Officer

Sold at will

12,500

$250.00K

4.2%

VKTX Viking Therapeutics, Inc.

29 Mar 2023

Chief Operating Officer

Sold at will

41,242

$659.87K

13.6%

VKTX Viking Therapeutics, Inc.

28 Mar 2023

Chief Operating Officer

Sold at will

196,563

$2.95M

40.6%

10 decisions on file.